Material Type

• Blood (whole) (2)
• Buffy coat (1)
• Dried whole blood (1)
• Isolated peripheral blood mononuclear cells (viable) (2)
• Other (1)
• Pathogen DNA (Derivative) (1)
• Plasma (double spun) (2)
• Plasma (single spun) (2)
• Red Blood Cells (1)
• Serum (4)
• Stool (3)

Microscopic Assessment

• Not applicable (5)

Storage Temperature

• -35°C to -18°C (2)
• -85°C to -60°C (5)
• Liquid nitrogen (2)

Preservation Type

• N/A (1)

Associated Data

• Biomarker datasets (1)
• Clinical records (2)
• Followup records (2)
• Freezer temperature logs (5)
• Genomic datasets (2)
• Microbiological results (1)
• Participant Ethnicity (1)
• Quality indicators (1)
• Survey data (3)
• Treatment records (2)

Timeframe

• Immediate (1)
• 0 - 3 months (4)
• 3 - 6 months (2)
• > 6 months (1)

Participant Count

• 101 - 500 (5)

Sex

• Both sexes (5)

Age Range

• Young child (2 - 6 years) (3)
• Child (6 - 12 years) (3)
• Adolescent (12 - 18 years) (2)
• Young adult (18 - 40 years) (3)
• Adult (> 40 years) (3)

Biobank Services

• Ability to recontact (1)
• Cell culture (2)
• Digital imaging (1)
• Molecular Extractions (1)
• Nucleic acid extraction (2)

Collection Type

• Case-control (1)
• Cohort (1)
• Cross-sectional (3)

Consent Restriction

• No Commercial restriction (5)
• No Disease area restriction (4)
• No Genetic analysis restriction (5)
• No Human genetic analysis restriction (5)
• No restrictions (2)
• No Project specific restriction (3)
• No Scope of use restriction (5)

Collection Status

• Completed (2)
• In progress (3)
• Not-started (1)

Access Condition

• Open to applicants (1)
• Open only through collaboration (5)

Country

• Belgium (1)
• India (1)
• Spain (1)
• Uganda (1)
• United States (1)

County